Paris, January 27, 2010 – Cellectis S.A. (Alternext: ALCLS), the French genome engineering specialist, has won a National Innovation Award from the French National Institute for Industrial Property (INPI). Cellectis IP Manager Michèle Paquier received the award from Thierry Morin, President of the INPI Board, during a ceremony at the Pavillon Gabriel venue in Paris.
The awards, organized annually by the INPI since 1991, honor small and medium-sized companies whose growth can be attributed to their outstanding innovation policies and which use a comprehensive intellectual property (IP) strategy to leverage business growth: economic intelligence, technology watching, IP rights (including patents, trademarks, registered designs and registered models), managing and exploiting license agreements, and combating infringement. After a regional competition, a panel of judges selects the national award winners.
“Cellectis represents a fine balance between research activities and a healthy management,” declared Thierry Morin. “2009 was a very busy year for Cellectis in terms of IP,” said Cellectis CEO André Choulika. “We filed 15 new patent applications and had four patents granted. We also acquired the Vectocell® technology which has added an additional nine new patent families to our portfolio,” he added.
To date, Cellectis holds a portfolio of 58 granted patents for a total of more than 260 patents and patent applications More information : http://www.cellectis.com/
